MLN-1117
MLN-1117 is an orally bioavailable class I phosphoinositide 3-kinase (PI3K) alpha isoform inhibitor with potential anti-tumor activity. MLN-1117 selectively inhibits PI3K alpha kinases in the PI3K/Akt/mTOR pathway, including PIK3CA mutations, which may lead to tumor cell apoptosis and inhibit the growth of PI3K alpha-expressing tumor cells.
| Supplier | Alfa Cytology |
|---|---|
| Product # | BC0170 |
| Pricing | 10.0 mg, 25.0 mg, 50.0 mg, 100.0 mg, 200.0 mg, 500.0 mg, 1.0 g, 2.0 g, inquire |